Target intelligence / Profile preview

Ubiquinol-cytochrome c reductase binding protein pseudogene 3 (UQCRBP3)

Target
UQCRBP3
Molecular classification
Pseudogene
01

Overview

Ubiquinol-cytochrome c reductase binding protein pseudogene 3 (UQCRBP3) is a human pseudogene, meaning it is a non-protein-coding remnant of a gene. It is not a protein-coding gene or protein target. UQCRBP3 is related by sequence to the UQCRB gene, which encodes a functional component of complex III in the mitochondrial respiratory chain, but UQCRBP3 itself does not produce a functional protein and is not implicated as a therapeutic target or a biomarker. "Pseudogene" designates that this genomic locus resembles a protein-coding gene but is considered nonfunctional due to genetic alterations such as frame-shifts or premature stop codons. There are no known biological functions, disease roles, or drugs directly associated with UQCRBP3. It is not considered a valid drug target or receptor, nor is it implicated in any known therapeutic context. If the intention was to refer to UQCRB (the functional mitochondrial binding protein), then the characteristics and roles would be substantially different. UQCRBP3 does not have recognized roles in disease, drug interactions, or biomarker utility, nor is it classified in the standard molecular target families used in pharmacology.

Other names
UQCRBP3Ubiquinol-Cytochrome C Reductase Binding Protein Pseudogene 3

Beyond the preview

Go deeper on Ubiquinol-cytochrome c reductase binding protein pseudogene 3 (UQCRBP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquinol-cytochrome c reductase binding protein pseudogene 3 (UQCRBP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call